Sort
78,016 grants matching “breast cancer”
MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer
$667,192Jonine Lisa Bernstein · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
SYSTEMATIC ANALYSIS OF THE FUNCTIONAL RELEVANCE OF NUCLEAR STRUCTURE AND MECHANICS IN BREAST CANCER PROGRESSION
$667,112Cornell University · · FY2011 · Department of the Army
High Frame Rate 3-D Super Resolution Ultrasound Microvascular Imaging
$667,090Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Directed Transport Physics and Muli-Scale Therapy of Colon Cancer Liver Metatasis
$667,071Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2013 · CA
Marshfield Community Clinical Oncology Program
$667,064Matthias Weiss · Marshfield Clinic Research Foundation · U10 · FY2007 · CA
Fruit exosome-like particles for therapeutic delivery of extracellular miRNAs
$667,057Huang-Ge Zhang · University Of Louisville · UH3 · FY2015 · TR
MOUSE CANCER MODELS VIA TGF-BETA RII LOSS
$667,035Vanderbilt University · U01 · FY2000 · CA
Sleep Disturbance, Inflammation, and Cellular Aging in Breast Cancer Survivors
$666,998Michael R Irwin · University Of California Los Angeles · R01 · FY2016 · CA
Methylation and mutations in RB1 and variants of synthetic folic acid metabolism
$666,923Manuela A Orjuela · Columbia University Health Sciences · R01 · FY2015 · CA
Addressing the Biology of Health Disparities by Targeting Geographical Ancestry-driven Variants of Immunity
$666,881Kevin Sean Kimbro · Morehouse School Of Medicine · R01 · FY2025 · MD
Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers
$666,846Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
COMMUNITY TRIAL TO INCREASE CANCER SCREENING ADHERENCE
$666,833Rand Corporation · R01 · FY2001 · CA
Immuno-Isolating capsule for delivery of cell-based therapy for restoration of ovarian endocrine function in an animal model
$666,807Ariella Shikanov · University Of Michigan At Ann Arbor · R01 · FY2024 · HD
Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases
$666,767Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2023 · CA
Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases
$666,767Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2022 · CA
Intratumor heterogeneity underlying treatment resistance in HER2+ breast tumors
$666,735Kornelia Polyak · Dana-Farber Cancer Inst · U01 · FY2017 · CA
RES FACIL CONSTRUCTION: BREAST CANCER
$666,680New York Structural Biology Center · C06 · FY2002 · RR
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE
$666,678University Of Colorado · N01 · FY2013 · HD
Innovative Scan Protocols With Combined Long Axial FOV PET and Spectral CT for Improved Quantification in Oncology
$666,670Joel S Karp · University Of Pennsylvania · R01 · FY2025 · CA
Novel Markers for Disease Outcome in Breast Cancer
$666,640Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM
$666,622Cambridge Research And Instrumentation · R44 · FY2003 · CA
Immuno-Isolating capsule for delivery of cell-based therapy for restoration of ovarian endocrine function in an animal model
$666,537Ariella Shikanov · University Of Michigan At Ann Arbor · R01 · FY2025 · HD
CANCER AND LEUKEMIA GROUP B
$666,421Brigham And Women'S Hospital · U10 · FY2001 · CA
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials
$666,397Andre Rogatko · Cedars-Sinai Medical Center · U01 · FY2020 · CA
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials
$666,397Mourad Tighiouart · Cedars-Sinai Medical Center · U01 · FY2021 · CA